Sipuleucel-T: Immunotherapy for Advanced Prostate Cancer

Research and Reports in Urology - New Zealand
doi 10.2147/rru.s13069
Full Text
Abstract

Available in full text

Categories
Urology
Date
Authors
Publisher

Informa UK Limited

Related search

Sipuleucel-T: Autologous Cellular Immunotherapy for Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate Resistant Prostate Cancer

Journal of Cancer
Oncology
2011English

Entering a New Era – Prostate Cancer Immuno-Therapy After the FDA Approval for Sipuleucel-T

2011English

Microsatellite Instability May Predict Response to Sipuleucel-T in Patients With Prostate Cancer

Clinical Genitourinary Cancer
OncologyUrology
2019English

Vaccine Immunotherapy for Prostate Cancer

2012English

Immunotherapy in Prostate Cancer

The Bulletin of Urooncology
2019English

Dendritic Cell-Based Immunotherapy for Prostate Cancer

CA - A Cancer Journal for Clinicians
OncologyHematology
1999English

Natural Killer T Cells Subsets in Cancer, Functional Defects in Prostate Cancer and Implications for Immunotherapy

Cancers
Cancer ResearchOncology
2011English

The Immunotherapy of Prostate Cancer

Prostate Cancer and Prostatic Diseases
Cancer ResearchOncologyUrology
2000English

Exenterative Surgery for Advanced Prostate Cancer

Current Surgery Reports
Surgery
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy